The present invention relates to the treatment of cancer. Here, the inventors evaluated EAPB02303 effects in PDAC cell lines and mouse models and […]

Immunotherapy has transformed cancer treatment but often struggles with solid tumors due to immune resistance from the tumor microenvironment (TME). […]

Melanoma cell plasticity plays a key role in the acquisition of resistance to therapy. TRIM24/TIF1α, which encodes for the tripartite […]

The Inventors herein demonstrate that CD39 is a relevant therapeutic target in B-celllymphoma, in particular Follicular Lymphoma (FL), Diffuse Large […]

The cholangiocarcinoma cell line SB1-JP4 is syngeneic to C57Bl/6 mice.It was derived from a tumor formed by SB1 cells in C57Bl/6 mice, then harvested, […]

The present invention relates to cardiovascular event in a patient with type 2 diabetes. In a cross-sectional study population of 672 participants […]

The Alpha haemoglobin-stabilising protein (AHSP) is a key chaperone molecule synthesised in red blood cell (RBC) precursors. In this study, the […]

The inventors developed a novel and reliable top-down RPLC-MS method for the absolute quantification of the most relevant isoforms of HSA using an […]

PTLDs arise after solid organ and hematopoietic stem cell transplants, with occurrences linked to immunosuppressive therapy and EBV status. Initial […]

[…]